TB treatment: comparing immune system strength
Part of Infections clinical trials.
This trial compares how well tuberculosis (TB) treatment works in people with healthy immune systems versus those with weakened immune systems. It looks at patients who already have a chronic chest condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a long-term chest condition, such as chronic bronchitis or another chronic lung disease.
- You have been diagnosed with active tuberculosis (TB).
- You do not have any other lung or infectious diseases (like pneumonia or COVID-19) at this time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
This study looks at how well your immune system controls tuberculosis (TB) bacteria. It uses a blood test to measure immune responses in healthy people and those who have been vaccinated against TB.
This study examines how different types of mycobacterial infections (including tuberculosis) affect your body's immune response. Researchers will compare immune function across different TB types and drug-resistance patterns to better understand the disease and improve treatment.
This study aims to better understand how the immune system responds to tuberculosis (TB) and improve tools for diagnosing and managing the disease. It may help people with active TB, their close contacts, people with certain other lung diseases, or healthy individuals.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This study looks for people who have recently completed standard treatment for drug-sensitive TB. Researchers want to check if certain tests can predict long-term health outcomes after treatment.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.